MarketLens

Log in
Stock AnalysisPro

Why Did GSK Pay $10.6 Billion for Nuvalent

1 months ago
SHARE THIS ON:

Why Did GSK Pay $10.6 Billion for Nuvalent

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Why Did Gilead Pay $7.8 Billion for Arcellx

Why Did Gilead Pay $7.8 Billion for Arcellx

5 months ago
Why Did Alphabet Pay a Record $32 Billion for Wiz

Why Did Alphabet Pay a Record $32 Billion for Wiz

4 months ago
Why Did Google Pay a Record-Breaking $32 Billion for Wiz

Why Did Google Pay a Record-Breaking $32 Billion for Wiz

4 months ago
What's Behind Whoop's Soaring $10 Billion Valuation

What's Behind Whoop's Soaring $10 Billion Valuation

3 months ago

Category

TopFeaturedPro OnlyStock AnalysisInvestment IdeasETFsCryptoNew Release

You may also like

Stock News•1 week ago

GSK: Buy The Discount Before The Catalysts Close It

GSK trades at a 42% discount to pharma peers, despite resilient earnings through the dolutegravir patent cliff. HIV franchise shift to long-acting injectables drives 30–44% growth, while Nuvalent acqu...
GSK
Stock News•1 months ago

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Nuvalent, Inc. (NASDAQ: NUVL)

Nuvalent (NUVL) is under investigation by Monteverde & Associates regarding its $124.00/share sale to GSK, raising questions about deal fairness for shareholders.
NUVL
Stock News•1 months ago

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

GSK will acquire Nuvalent for $10.6 billion, gaining three lung cancer drug candidates, including two under FDA review for approval this year.
GSK
Stock News•2 months ago

Nuvalent: A Precision Oncology Platform With Two Near-Term Shots On Goal

Nuvalent maintains a $1.37B cash position following a $500M raise, extending its operational runway through 2029. The company is advancing two precision oncology assets, with a PDUFA date for zidesamt...
NUVL

Breaking News

View All →
Earnings
Event-Driven Investing
Corporate Earnings
Financials
IPOs
REITs
Semiconductor Stocks

Featured Articles

SanDisk's AI Supercycle Meets a Skeptical Market

SanDisk's AI Supercycle Meets a Skeptical Market

5 hours ago
Intel's Q2 Beat Ignites Short-Term Call Mania Amidst CHIPS-Fueled Ambition

Intel's Q2 Beat Ignites Short-Term Call Mania Amidst CHIPS-Fueled Ambition

5 hours ago
Coca-Cola’s Bullish Call Block Signals Underpriced Strategic Momentum

Coca-Cola’s Bullish Call Block Signals Underpriced Strategic Momentum

6 hours ago

Top Headlines

View More →
Stock News•1 hour ago

Microsoft Corporation (MSFT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Stock News•2 hours ago

Nvidia Stock Is Trading at a Shocking Valuation. Now Is the Perfect Time to Buy

Stock News•2 hours ago

A $1.2 Million Portfolio That Pays $7,000 a Month and Stays Below the IRMAA Surcharge Line

Stock News•2 hours ago

Apple Is Set to Report Earnings Thursday. Here's How Much The Stock Is Expected to Move

Stock News•3 hours ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Microsoft Corporation of Class Action Lawsuit and Upcoming Deadlines – MSFT